Expanding the SPD Business Through New Contracts with Large Facilities
First written in FY2016. 22 of 38 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
2 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As a result of activities to pass higher purchase prices through to selling prices, continued negotiations to raise management fees in response to inflation, and steady growth in contracts for Medilia®, our Group’s proprietary system supporting medical equipment management at small and medium-sized medical institutions, sales were ¥6,096 million, up 6.6% year on year.」
The SPD business increased revenue 6.6% from the previous fiscal year through price pass-throughs, management-fee negotiations, and an increase in Medilia contracts. - FY2026-H1AdvancedAnnual report
「In the SPD business, net sales were ¥3,027 million, up 6.5% year on year, and operating income was ¥64 million, up 16.9%, as a result of continuing efforts to pass higher procurement costs on to selling prices, negotiations to raise management fees in line with inflation, and steady growth in contracts for the group's original system, Medilia®, which supports medical equipment management at small and medium-sized medical institutions.」
In addition to passing through higher prices and negotiating management fees, an increase in system contracts complementing the existing SPD business drove revenue and operating profit above the previous year's levels. - FY2025-H1AdvancedAnnual report
「In the SPD business, revenue rose to ¥2,842 million, up 9.8% year on year, as the company continued passing higher procurement costs through to selling prices. Selling, general and administrative expenses also increased due to factors including salary increases, but operating profit rose to ¥55 million, up 5.3% year on year, as the company worked to revise management fees at existing contracted facilities and improve procurement.」
The SPD business delivered higher revenue and profit by passing higher procurement costs through to prices, revising management fees at existing facilities, and improving procurement. - FY2024Full-year lower revenue and profit due to lost contracts and implementation delaysAnnual report
「The SPD business was affected by the loss of certain customers in the previous fiscal year and delays in introducing facilities newly contracted in the current period, but revenue remained almost at the previous year's level at ¥5.223 billion, down 1.0% from the previous fiscal year, owing in part to reviews of management fees at existing contracted facilities. However, in addition to lower profit resulting from the loss of contracts in the previous fiscal year and decreased demand for PPE as COVID-19 subsided, higher labor costs caused operating profit to fall to ¥104 million, down 39.1% from the previous fiscal year.」
Although revisions to management fees at existing contracted facilities kept revenue broadly at the previous year's level, the business posted lower full-year revenue and profit due to lost contracts, delays in implementing newly contracted facilities, lower PPE demand, and higher labor costs. - FY2024-Q3Continued lower revenue and profit due to lost contracts and implementation delaysAnnual report
「The SPD business was affected by the loss of certain customers in the previous fiscal year and delays in introducing facilities newly contracted in the current period, but revenue remained almost at the previous year's level at ¥3.883 billion, down 0.1% year on year, owing in part to reviews of management fees at existing contracted facilities. However, in addition to lower profit resulting from the loss of contracts in the previous fiscal year and decreased demand for PPE as COVID-19 subsided, higher labor costs caused operating profit to fall to ¥83 million, down 43.6% year on year.」
Although revisions to management fees at existing contracted facilities kept revenue broadly at the previous year's level, operating profit fell 43.6% year on year due to contracts lost in the previous fiscal year, delays in implementing newly contracted facilities, lower PPE demand, and higher labor costs. - FY2024-Q2Higher revenue but lower profit due to lost contracts and implementation delaysAnnual report
「The SPD business was affected by the loss of contracts with some customers in the previous fiscal year and delays in implementing newly contracted facilities, but revenue rose to ¥2,590 million, up 0.9% year on year, owing to revisions to management fees at existing contracted facilities and other factors. However, in addition to lower profit resulting from contracts lost in the previous fiscal year and declining PPE demand as the pandemic subsided, operating profit fell to ¥52 million, down 46.5% year on year, due to higher labor costs.」
Although revisions to management fees at existing facilities secured higher revenue, profit fell sharply due to contracts lost in the previous fiscal year, delays in implementing newly contracted facilities, lower PPE demand, and higher labor costs. - FY2024-Q1Higher revenue but lower profit despite some lost contractsAnnual report
「The SPD business was affected by the loss of contracts with some customers in the previous fiscal year, but revenue increased to ¥1,258 million, up 1.3% year on year, owing to revisions to management fees at existing contracted facilities and continued strong demand for infection-control products. Meanwhile, selling, general and administrative expenses increased due to higher labor costs and other factors, resulting in operating profit of ¥26 million, down 43.7% year on year.」
Although contracts were lost with some customers, revenue increased through revisions to management fees at existing contracted facilities and demand for infection-control products. However, operating profit fell 43.7% year on year due to higher labor costs and other factors. - FY2023AdvancedAnnual report
「In the SPD business, revenue increased to ¥5,275 million, up 11.5% from the previous fiscal year, owing to revisions to management fees at existing contracted facilities and continued strong demand for infection-control products.」
The SPD business increased revenue 11.5% from the previous fiscal year through revisions to management fees at existing contracted facilities and demand for infection-control products. Operating profit still rose 0.5% despite higher fuel and labor costs. - FY2023-Q3AdvancedAnnual report
「In the SPD business, revenue increased to ¥3,887 million, up 11.3% year on year, owing to revisions to management fees at existing contracted facilities and continued strong demand for infection-control products. In addition, operating profit rose to ¥148 million, up 25.6% year on year, as closer cooperation with manufacturers improved procurement.」
The SPD business delivered higher revenue and profit through revisions to management fees at existing facilities, demand for infection-control products, and procurement improvements made in cooperation with manufacturers. - FY2023-Q2AdvancedAnnual report
「In the SPD business, revenue increased to ¥2,566 million, up 10.4% year on year, owing to revisions to management fees at existing contracted facilities and continued strong demand for infection-control products. In addition, operating profit rose to ¥97 million, up 59.2% year on year, as closer cooperation with manufacturers improved procurement.」
The SPD business delivered higher revenue and profit through revisions to management fees at existing contracted facilities, demand for infection-control products, and procurement improvements made in cooperation with manufacturers. Operating profit rose 59.2% year on year. - FY2023-Q1AdvancedAnnual report
「In the SPD business, revenue increased to ¥1,242 million, up 7.8% year on year, owing to revisions to management fees at existing contracted facilities and continued strong demand for infection-control products. In addition, operating profit rose to ¥47 million, up 71.9% year on year, as closer cooperation with manufacturers improved procurement.」
The SPD business increased revenue through revisions to management fees at existing facilities, demand for infection-control products, and procurement improvements made in cooperation with manufacturers. Operating profit also rose 71.9% year on year. - FY2022Full-year revenue and profit growth despite stagnation in new contractsAnnual report
「In the SPD business, sales activities aimed at securing new contracts made little progress because of COVID-19, but demand for infection-control products at existing contracted facilities remained high. As a result, revenue increased substantially more than selling, general and administrative expenses, with revenue of ¥4.732 billion, up 5.4% from the previous fiscal year, and operating profit of ¥170 million, up 27.8%.」
Although new contract acquisition remained sluggish, demand for infection-control products at existing contracted facilities drove full-year revenue and profit growth. - FY2022-Q3Continued stagnation in new contracts, with revenue growth and lower profit driven by demand for infection-control productsAnnual report
「In the SPD business, sales activities aimed at securing new contracts made little progress because of COVID-19, but demand for infection-control products at existing contracted facilities remained high, and revenue increased to ¥3.492 billion, up 5.6% year on year. Meanwhile, operating profit was ¥117 million, down 2.1% year on year, owing in part to higher labor costs accompanying changes to the salary system.」
While new contract sales continued to stagnate, revenue increased 5.6% year on year on demand for infection-control products at existing contracted facilities. However, operating profit fell 2.1% due to higher personnel costs and other factors. - FY2022-Q2Continued stagnation in new contracts, with revenue growth and lower profit driven by demand for infection-control productsAnnual report
「In the SPD business, sales activities aimed at securing new contracts made little progress because of COVID-19, but demand for infection-control products at existing contracted facilities remained high, and revenue increased to ¥2.324 billion, up 7.1% year on year. Meanwhile, operating profit was ¥61 million, down 17.2% year on year, owing in part to higher labor costs accompanying changes to the salary system.」
While new contract sales continued to stagnate due to COVID-19, revenue increased on demand for infection-control products at existing contracted facilities. Revenue rose 7.1% year on year, but operating profit fell 17.2% due to higher personnel costs associated with changes to the compensation system and other factors. - FY2022-Q1Revenue growth but lower profit amid stagnation in new contracts, driven by demand for infection-control productsAnnual report
「Sales activities leading to new SPD contracts did not progress due to the impact of COVID-19, but revenue increased 12.2% year on year to ¥1,152 million, driven by stronger demand for infection-control products at existing contracted facilities. However, operating profit fell 27.1% year on year to ¥27 million due to higher personnel costs associated with changes to the compensation system and other factors.」
While new contract sales stagnated due to COVID-19, revenue increased 12.2% year on year on demand for infection-control products at existing contracted facilities. Operating profit fell 27.1% due to higher personnel costs resulting from changes to the compensation system and other factors. - FY2021AdvancedAnnual report
「The SPD business generated revenue of ¥19,288 million, up 7.5% from the previous fiscal year, as facilities newly contracted in the previous fiscal year operated steadily and demand for PPE-related products increased. Operating profit increased 54.8% to ¥133 million as the company continued to revise its inventory management service fees and improve procurement.」
The SPD business generated higher revenue, and operating profit increased 54.8% from the previous fiscal year, driven by the operation of newly contracted facilities, PPE demand, revisions to inventory management service fees and improved procurement. - FY2021-Q3AdvancedAnnual report
「In the SPD business, net sales were ¥14,382 million, up 5.9% year on year, due to the smooth start-up of facilities newly contracted in the previous fiscal year and increased demand for PPE-related products. In addition, as a result of continuing to review the fees for inventory management services and improve the procurement of consumables, operating income was ¥120 million, up 73.6% year on year.」
Revenue and operating profit both increased due to the operation of facilities newly contracted in the previous fiscal year, demand for PPE, revisions to inventory management service fees and improved procurement. - FY2021-Q2AdvancedAnnual report
「The SPD business generated revenue of ¥9,677 million, up 6.2% year on year, as facilities newly contracted in the previous fiscal year operated steadily and demand for PPE-related products increased. Operating profit increased 83.0% year on year to ¥74 million as the company continued to revise its inventory management service fees.」
In addition to the operation of facilities newly contracted in the previous fiscal year and increased demand for PPE-related products, the company continued to revise its inventory management service fees. Revenue increased 6.2% year on year, while operating profit increased 83.0%. - FY2021-Q1AdvancedAnnual report
「In the SPD business, facilities newly contracted in the previous fiscal year became operational as planned, resulting in revenue of ¥4.678 billion, up 6.2% year on year. In addition, following the continued review of materials management service fees, operating profit was ¥37 million, up 114.1% year on year.」
The company continued to operate facilities newly contracted in the previous fiscal year and revise its inventory management service fees. Revenue increased 6.2% year on year, while operating profit increased 114.1%. - FY2020AdvancedAnnual report
「In the SPD business, facilities newly contracted in the previous fiscal year became operational as planned, supporting results. In addition, following the continued review of materials management service fees, revenue was ¥17.944 billion, up 8.4% from the previous fiscal year, and operating profit was ¥86 million, up 11.7%.」
The company continued to operate facilities newly contracted in the previous fiscal year and revise its inventory management service fees, resulting in increases in both revenue and operating profit. - FY2020-Q3AdvancedAnnual report
「In the SPD business, facilities newly contracted in the previous fiscal year became operational as planned, supporting results. In addition, following the continued review of materials management service fees, revenue was ¥13.578 billion, up 11.3% year on year, and operating profit was ¥69 million, up 22.3%.」
The company continued to operate facilities newly contracted in the previous fiscal year and revise its inventory management service fees. Revenue increased 11.3% year on year, while operating profit increased 22.3%. - FY2020-Q2AdvancedAnnual report
「In the SPD business, facilities newly contracted in the previous fiscal year became operational as planned, contributing to results. In addition, following a review of materials management service fees, revenue was ¥9.112 billion, up 11.0% year on year, and operating profit was ¥40 million, up 21.9%.」
In addition to the operation of facilities newly contracted in the previous fiscal year, the company revised its inventory management service fees. Revenue increased 11.0% year on year, while operating profit increased 21.9%. - FY2020-Q1AdvancedAnnual report
「The SPD business generated revenue of ¥4,405 million, up 13.0% year on year, and operating profit of ¥17 million, up 126.7%, as facilities newly contracted in the prior period operated steadily.」
As facilities newly contracted in the previous fiscal year began operations, the SPD business generated higher revenue, and operating profit increased 126.7% year on year. - FY2019AdvancedAnnual report
「The SPD business generated revenue of ¥16,556 million, up 1.3% from the prior period, despite the termination of some major contracts, as it acquired contracts with 3 new facilities. Efforts to reduce expenses through optimisation of personnel allocation and logistics operations also resulted in operating profit of ¥77 million, up 29.2% from the prior period.」
Although a major contract ended, revenue increased after 3 new facilities were won, and operating profit rose 29.2% from the previous fiscal year through optimization of staffing and logistics operations. - FY2019-Q3AdvancedAnnual report
「The SPD business generated revenue of ¥12,199 million, down 0.4% year on year, due to the termination of some major contracts. However, efforts to reduce expenses through optimisation of personnel allocation and logistics operations resulted in operating profit of ¥56 million, up 7.3% year on year.」
Although revenue declined following the termination of some major contracts, the company pursued cost reductions by optimizing staffing and logistics operations, resulting in operating profit increasing 7.3% year on year. - FY2019-Q2Revenue growth and slight operating profit decline following the termination of a major contractAnnual report
「The SPD business generated revenue of ¥8,210 million, up 0.5% year on year, as newly contracted facilities operated steadily. However, operating profit was ¥33 million, down 0.2% year on year, due to the termination of a major contract in part of the business.」
Revenue increased as newly contracted facilities began operations, while operating profit fell 0.2% year on year due to the termination of some major contracts. - FY2019-Q1Revenue and profit decline following the termination of a major contractAnnual report
「The SPD business achieved 108.2% of the prior-year period in the Shikoku region as newly contracted facilities operated steadily. However, a major contract ended in the Chugoku region, resulting in revenue of ¥3,900 million, down 1.2% year on year, and operating profit of ¥7 million, down 62.0%.」
Although revenue increased in Shikoku as newly contracted facilities began operations, a major contract ended in the Chugoku region, resulting in lower revenue and a significant decline in profit for the business overall. - FY2018Higher revenue, lower profitAnnual report
「The SPD business generated revenue of ¥16,348 million, up 5.9% from the previous fiscal year, as facilities newly contracted last year operated steadily and surgeries increased at facilities under existing contracts. However, operating profit fell 42.2% from the previous fiscal year to ¥59 million due to higher personnel costs and a temporary increase in expenses from the initial costs of the new logistics hub opened to reduce operating costs.」
Revenue increased as newly contracted facilities began operations and surgeries increased at existing facilities, while profit declined due to personnel recruitment costs and initial costs for the logistics hub. - FY2018-Q3AdvancedAnnual report
「The SPD business generated revenue of ¥12,252 million, up 6.1% year on year, as facilities newly contracted last year operated steadily and surgeries increased at facilities under existing contracts. However, operating profit fell 37.2% year on year to ¥52 million due to higher personnel costs and initial costs incurred in opening a new logistics hub to reduce operating costs.」
Revenue increased as facilities contracted in the previous year began operations and surgeries increased at existing facilities, while profit declined due to initial costs for the newly opened logistics hub and personnel recruitment costs. - FY2018-Q2Revenue growth but lower operating profit amid new orders and contract terminationsAnnual report
「The SPD business had 1 new order and 1 contract termination, but revenue increased 6.9% year on year to ¥8,173 million as facilities newly contracted last year operated steadily and surgeries increased at facilities under existing contracts. However, higher personnel costs required to secure staff resulted in operating profit falling 29.7% year on year to ¥33 million.」
There was 1 new order and 1 contract termination. Revenue increased on higher utilization and more surgeries at facilities under existing contracts, while operating profit fell 29.7% year on year due to higher personnel recruitment costs. - FY2018-Q1AdvancedAnnual report
「The SPD business generated revenue of ¥3,946 million, up 6.7% year on year, and operating profit of ¥20 million, up 5.3%, as facilities newly contracted in the prior year operated steadily and surgeries increased at existing contracted facilities.」
Revenue and operating profit both increased year on year, driven by the operation of facilities newly contracted in the previous year and an increase in surgeries at facilities under existing contracts. - FY2017ReframedAnnual report
「2. Improve efficiency through accurate customer inventory management and achieve rational procurement prices through purchasing support」
In addition to the expansion achieved by launching SPD services at 5 new facilities and undertaking system renewal projects, the company is defining SPD's role as improving the efficiency of inventory management and rationalizing purchase prices through procurement support. - FY2017-Q3AdvancedAnnual report
「The SPD business expanded both revenue and operating profit as SPD services were newly launched at 5 facilities from the start of the current period and some customers updated their systems.」
SPD services were newly launched at 5 facilities, and system renewal projects at customers also occurred, resulting in growth in both revenue and operating profit. - FY2017-Q2AdvancedAnnual report
「The SPD business newly launched SPD services at 5 facilities from the start of the current period. However, this was insufficient to offset the decline in profit from contracts terminated in the prior period.」
SPD services were newly launched at 5 facilities, but the decline in profit from contracts terminated in the previous fiscal year was not offset, and operating profit fell 6.7% year on year. - FY2017-Q1AdvancedAnnual report
「The SPD business generated revenue of ¥3,697 million, up 3.6% year on year, as SPD services were newly launched at 2 facilities this fiscal year and surgeries increased at existing facilities. However, operating profit fell 17.6% year on year to ¥19 million, as the increase did not fully offset the decline in profit from contracts lost in the previous fiscal year.」
SPD services were newly launched at 2 facilities and revenue increased, but the decline in profit from contracts lost in the previous fiscal year was not fully offset, resulting in lower operating profit. - FY2016First statedAnnual report
「Although one existing facility was lost following a review of its SPD contract, revenue grew steadily, supported by new contracts with large facilities and the contribution throughout the year from customers newly contracted in the previous fiscal year.」
While some existing contracts were lost, the company is pursuing growth through new contracts with large facilities and full-year contributions from existing newly contracted customers.